Advances in the diagnosis and immunotherapy for ocular inflammatory disease.
Significant advances in the diagnosis and therapy for uveitis have been made to improve the quality of care for patients with ocular inflammatory diseases. While traditional ophthalmic examination techniques, fluorescein angiography, and optical coherence tomography continue to play a major role in the evaluation of patients with uveitis, the advent of spectral domain optical coherence tomography and fundus autofluorescence into clinical practice provides additional information about disease processes. Polymerase chain reaction and cytokine diagnostics have also continued to play a greater role in the evaluation of patients with inflammatory diseases. The biologic agents, a group of medications that targets cytokines and other soluble mediators of inflammation, have demonstrated promise in targeted immunotherapy for specific uveitic entities. Their ophthalmic indications have continued to expand, improving the therapeutic armentarium of uveitis specialists.
Yeh
Steven
S
Laboratory of Immunology, National Eye Institute, National Institutes of Health, Building 10, 10S-219, 10 Center Dr., Bethesda, MD 20892-1857, USA.
Faia
Lisa J
LJ
Nussenblatt
Robert B
RB
D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D014605:Uveitis / Q000175:diagnosis* / Q000276:immunology* / Q000628:therapy*